Efficacy of Oral Alitretinoin Treatment in Patients With Palmo-plantar Pustulosis (PPP) Inadequately Responding to Standard Topical Treatment.
Phase of Trial: Phase II
Latest Information Update: 27 Dec 2017
At a glance
- Drugs Alitretinoin (Primary)
- Indications Palmoplantar pustulosis
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline
- 22 Jan 2016 Results published in the British Journal of Dermatology
- 03 May 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 01 Nov 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.